• About
    • Overview
    • Leadership
    • Board Of Directors
    • Our Culture
    • Gallery
  • Product Portfolio
    • Technology
    • Pipeline
    • ZTLido®
    • Elyxyb®
    • Gloperba®
    • Expanded Access Policy
  • Partners
  • Science
    • Medical information U.S.
    • Publications
  • Investors
    • Investors Overview
    • News & Events
    • Presentations
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
    • FAQs
  • Join Our Team
  • Contact Us
    • Contact Us
    • Locations
Shopping cart close
Scilex Holding Scilex Holding
  • About
    • Overview
    • Leadership
    • Board Of Directors
    • Our Culture
    • Gallery
  • Product Portfolio
    • Technology
    • Pipeline
    • ZTLido®
    • Elyxyb®
    • Gloperba®
    • Expanded Access Policy
  • Partners
  • Science
    • Medical information U.S.
    • Publications
  • Investors
    • Investors Overview
    • News & Events
    • Presentations
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
    • FAQs
  • Join Our Team
  • Contact Us
    • Contact Us
    • Locations

Posts by Jitendra

Home » Articles Posted by Jitendra (Page 7)
02 Feb
SEC FIlings

Current report

  • February 2, 2023
  • Posted by Jitendra

Read more

29 Jan
Press Release

Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

  • January 29, 2023
  • Posted by Jitendra
Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock PALO ALTO, January 29, 2023 (GLOBE NEWSWIRE)...

Read more

03 Jan
SEC FIlings

Current Report

  • January 3, 2023
  • Posted by Jitendra

Read more

09 Dec
SEC FIlings

Notice of Effectiveness

  • December 14, 2022
  • Posted by Jitendra

Read more

09 Dec
SEC FIlings

Prospectus [Rule 424(b)(3)]

  • December 12, 2022
  • Posted by Jitendra

Read more

09 Dec
SEC FIlings

Statement of acquisition of beneficial ownership by individuals – amendment

  • December 14, 2022
  • Posted by Jitendra

Read more

02 Dec
SEC FIlings

Statement of changes in beneficial ownership of securities

  • December 14, 2022
  • Posted by Jitendra

Read more

30 Nov
SEC FIlings

 IPO Investment Prospectus

  • November 30, 2022
  • Posted by Jitendra

Read more

25 Nov
SEC FIlings

Statement of changes in beneficial ownership of securities

  • December 14, 2022
  • Posted by Jitendra

Read more

23 Nov
SEC FIlings

Statement of changes in beneficial ownership of securities

  • December 14, 2022
  • Posted by Jitendra

Read more

«‹56789›»
Close
Recent Posts
  • Nasdaq_Gloperba03
    Gloperba Launch – Nasdaq-2024
    July 10, 2024 No Comments
  • A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain
    June 14, 2024 No Comments
  • Gout Awareness Day – May 22
    May 20, 2024 No Comments
  • Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis
    March 14, 2024 No Comments
  • Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch
    March 14, 2024 No Comments

scilex-holding-logo-white

Terms of Use  Privacy Policy  Contact

  • Follow us on Facebook
  • Follow us on LinkedIn
  • Contact us by email

©2024 Scilex Holding All Rights Reserved
Scilex Holding Company is the owner of Scilex Pharmaceuticals and Semnur Pharmaceuticals

Scroll To Top Sidebar
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
Accept More info